Ye et al. determined that JCAD was highly expressed in human nonalcoholic steatohepatitis-associated hepatocellular carcinoma (HCC) specimens, as well as in some hepatoma cell lines. The gene discussed is JCAD; the disease is metabolic dysfunction-associated steatohepatitis.